Trial Details

TERMINATED
Basic Information
Clinical ID c3885
Identifier NCT01375179
Trial Title Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: KRP203|DRUG: Placebo matching KRP203
Participant Information
Sponsor Novartis Pharmaceuticals
City Ghent
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2010-12
Primary Completion Date 2012-05
Completion Date 2012-05